Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Fairfield Financial Advisors »

Neurocrine Biosciences shares owned by Fairfield Financial Advisors

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Fairfield Financial Advisors from 13F filings

Historical chart of Fairfield Financial Advisors investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Fairfield Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Fairfield Financial Advisors

Quarter filed	Position value	Share count	Share price at filing
2024-09-30	$12k	100	115.22
2024-06-30	$14k	100	137.67
2023-12-31	$13k	100	131.76

More positions owned by Fairfield Financial Advisors

Invsc Qqq Trust Srs 1 Etf Uit Exchange Traded (QQQ)

Technology Select Sectorspdr Etf Uit Exchange Traded (XLK)

Jensen Quality Growth I Equity Funds (JENIX)

Parnassus Core Equity Investor Ntf Equity Funds (PRBLX)

T. Rowe Price Capital Appreciation I Ntf Equity Funds (TRAIX)

Vanguard Dividend Growth Fund Inv Equity Funds (VDIGX)

Eli Lilly And Common Stock (LLY)

Apple Common Stock (AAPL)

Amazon.com Common Stock (AMZN)

Alphabet Inc Class A Common Stock (GOOGL)

Berkshire Hathaway Class B Common Stock (BRK.B)

Microsoft Corp Common Stock (MSFT)

Automatic Data Processin Common Stock (ADP)

Novo-nordisk A S Fsponsored Adr 1 Adr Reps 1 Ord American Depository (NVO)

Schwab Value Advantage Money Investor Shares Schwab Non-sweep Mmf (SWVXX)

View all positions for Fairfield Financial Advisors

Top funds holding Neurocrine Biosciences

State Street Corporation

Renaissance Technologies

Geode Capital Management

Citadel Advisors

AQR Capital Management

T. Rowe Price Associates

Jpmorgan Chase & Co

Deerfield Management Company

Goldman Sachs Group

View all funds holding Neurocrine Biosciences

© 2024 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z